Worldwide legalization efforts are driving the global cannabis market growth

Twitter icon

According to data compiled by Verified Market Intelligence, the global cannabis market was valued at USD 42.2 Billion in 2017 and is expected to reach USD 466.81 Billion by 2025. The market is also set to grow at a CAGR of 35.3% during the period. The strong growth rate for the market is attributable to the widespread legalization of medical and recreational cannabis. Many nations are adopting medical cannabis treatment for therapeutic reasons, while some are exploring opportunities within the recreational market. The North American region had dominated the cannabis market last year, controlling 95% of the market value, as the U.S. alone drove in 90% of the revenue. Micron Waste Technologies Inc. (OTC: MICWF), KushCo Holdings, Inc. (OTC: KSHB), Emerald Health Therapeutics Inc. (OTC: EMHTF), Lexaria Bioscience Corp. (OTC: LXRP), Emblem Corp (OTC: EMMBF)

Canada recently legalized cannabis nationwide, becoming the first G-7 nation to do so. Canada's move marked a major milestone for the cannabis industry. Now, some U.S. states are voting for cannabis, while others are still considering legislative actions. A handful of states had cannabis legalization proposals on the ballots during the November midterm elections for both recreational and medical uses. Medical cannabis legalization was on the ballots for Missouri and Utah, while recreational legalization was on the ballots for North Dakota and Michigan. All of the ballot initiatives, "have a very good chance of passing," said Erik Altieri of the National Organization for the Reform of Marijuana Laws, according to CNBC. "Despite the pushback from Attorney General Sessions (or maybe because of), this year has been one of our most successful in terms of support… We've have more pieces of federal marijuana reform legislation introduced this year than in any other."

Micron Waste Technologies Inc. (OTC: MICWF) is also listed on the Canadian Securities Exchange under the ticker (CSE: MWM). Earlier this week, the Company announced, "the hiring and promotion of key management staff to build capabilities in business development, engineering and corporate relations.  

Business Development: Micron is pleased to announce Surj Uppal has joined the Company as Vice President, Business Development. Mr. Uppal brings over 20 years of experience as a marketing and demand generation professional with some of Canada's top employers including Save-On-Foods, McDonald's Canada, the BC Lottery Corporation and the Jim Pattison Auto Group, leveraging growth, rejuvenation and optimization strategies depending on the business need. Mr. Uppal brings his proven leadership in the Grocery, Quick Service Restaurant (QSR) Food Service, Gaming and Automotive industries to help guide the Micron's growth. Mr. Uppal was previously the Director of Marketing for the 23-dealership, 12-brand Jim Pattison Auto Group. Prior, he was Regional Marketing Manager, Western Canada, for McDonald's, as well as holding senior positions in the grocery and gaming industries.

"Micron is pleased to welcome Surj to the team at this key moment in the Company's development, as we pivot to commercial production of our cannabis and food waste processing systems," said Micron President Alfred Wong. "He brings proven leadership in building business relationships which support sales, marketing and strategic partnerships. We also welcome his expertise in the grocery and QSR industries, which are both key markets for Micron.'

Engineering: Micron is also pleased to announce Ziba Hajizadeh, P.Eng, has been promoted to Vice President, Engineering from Lead Process Engineer. Ms. Hajizadeh is a professional chemical engineer specializing in wastewater process design. She has extensive experience in multiple industries, including water treatment, beverage, oil and gas, and pulp and paper. Prior to joining Micron, Ms. Hajizadeh was a Production Engineer II at Linde North Americas in New Jersey, where she was a process and production engineer in charge of beverage grade CO2 and USP grade product for a global beverage company. While at Micron, she has focused on development of the Cannavore™ cannabis waste treatment system.

Story Continues Below

'Ziba has been instrumental in bringing the Cannavore™ from concept to commercial-stage,' said Dr. Bob Bhushan, Micron's Co-Founder and Chief Technology Officer. 'Her leadership capabilities and depth and breadth of industry expertise will serve the company well as we explore unmet waste processing needs in industries such as food and beverage, oil and gas, and pulp and paper.'

Corporate: Karen Lauriston has been promoted to Vice President, Corporate, overseeing communications and investor, community and government relations. Ms. Lauriston began her career as a reporter for the Ottawa Citizen and Winnipeg Free Press. She served as Legislative Assistant to the Hon. Dr. Rey Pagtakhan, M.P. at the House of Commons, and was Manager of Communications and Acting-Director, Government and Public Affairs, for the Canadian Pharmacists Association. She was Account Supervisor for the Toronto office of Fleishman-Hillard Inc. before becoming a partner in Health Strategy Group, a health care management consultancy.

'Karen's experience and skills have been a valuable asset in the articulation of Micron's vision,' said Mr. Wong. 'Across a wide variety of audiences, she has enabled us to communicate the benefits of our innovative, clean technology. In her expanded role, she'll continue to provide support for our teams as we enter commercialization, expand our R&D capabilities and increase shareholder value.'

Micron Waste Overview: Micron's food and cannabis waste treatment systems are industrial-grade organic waste processers which pulverize and render organic waste in combination with a proprietary blend of microbes and enzymes designed and developed by Micron. Importantly, as part of Micron's full-system waste treatment platform, effluent from the systems is further treated to derive clean greywater which can be reused in industrial or agricultural operation. Alternatively, the treated regulatory-compliant greywater, which meets municipal discharge standards, can be safely discharged. Active Pharmaceutical Compounds (APIs) in cannabis waste are further biologically treated to denature cannabinoids present, keeping them out of watersheds where they can bio-accumulate.

Micron's waste management systems also use advanced computer science for remote real-time diagnostics monitoring and control. The comprehensive systems have been engineered to operate on-site where needed in a contained unit which does not emit sound or smell, while exempting customers from the need to truck, incinerate or landfill methane-producing waste.

Micron's Cannavore™ waste system was engineered based on proven technology used by the Company in its food waste digester unit, which can be used for large-scale food waste processing by municipalities, Quick Service Restaurants (QSRs) and supermarkets. The Cannavore's design and development resulted from a collaboration with Aurora Cannabis Inc. (TSE: ACB) to develop a clean technology solution to process waste generated from the cultivation of cannabis.

Micron's Cannavore Digester and Organic Waste Digester units has been awarded an Industrial Design Certificate of Registration from the Canadian Intellectual Property Office (CIPO), with patent pending in the United States."

KushCo Holdings, Inc. (OTCQB: KSHB) is the parent company to a diverse group of business units that are transformative leaders across several industries. KushCo Holdings, Inc. recently announced that it had formed a new Advisory Board to provide strategic advice and expertise to help accelerate growth, manage risk and enhance operational performance. Its first three appointments are Matthew Morgan, an entrepreneur and business consultant with leadership experience in the cannabis and other CPG industries, Eric Smith, an industry veteran in the Liquefied Petroleum Gas industry, and Ali Jahangiri, a digital publishing pioneer who has established and grown several businesses. "As we continue to expand the business, forming a well-rounded Advisory Board will serve as an additional resource to guide our rapid growth. We plan to add more experts to the Advisory Board, across a range of relevant industries over time, to provide diverse and complementary insights to the different areas of our business we service today, as well as how we will evolve in the future," said Nick Kovacevich, Chief Executive Officer of KushCo. "Mr. Morgan, Mr. Smith and Mr. Jahangiri each bring a wealth of skills and experience to KushCo that will assist in positioning the Company for sustained, accelerated growth, both within the expanding cannabis market as well as the new markets we are targeting. Together, they provide a diversified set of skills, supported by strong networks, that will help us navigate the challenges we face as a rapidly growing public company and help better position us to achieve our lofty goals. I look forward to their close involvement in the next phase of the Company's evolution."

Emerald Health Therapeutics, Inc. (OTCQX: EMHTF) is a Licensed Producer under Canada's Access to Cannabis for Medical Purposes Regulations. Emerald Health Therapeutics, Inc. recently filed 17 provisional US patent applications covering Emerald's unique Defined Dose™ cannabis dosage forms and formulations. Based on proprietary Emerald research, these patent applications are contributing to Emerald's intellectual property portfolio and its intent to develop distinctive cannabis products for medical-use and improved adult-use. The products provide more precise and consistent delivery, dosage, and formulations. Defined Dose™ cannabis products will, when made available to the public, provide consumers with products currently not available. "We expect significant potential cannabis market growth by offering adult users and medical consumers consistent product characteristics, dosing regimens, and alternative methods of consumption, with safety enhanced through GMP-compliant production and enhanced product utility achieved through knowledge of science. Emerald's filing of these patent applications is an important step," said Chris Wagner, Chief Executive Officer of Emerald. "Our expanding research and development effort is focused on internal facilities and staff as well as forming key relationships with other cannabis research experts, such as our recently announced agreement with VivaCell Biotechologies Espana."

Lexaria Bioscience Corp. (OTCQX: LXRP) has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria Bioscience Corp. recently announced that it has been granted two new U.S. patents. Lexaria now has six granted patents in the U.S. and four granted patents in Australia. All ten of these patents are within Lexaria's first patent family, "Food and Beverage Compositions Infused with Lipophilic Active Agents and Methods of Use Thereof". Specifically, the two new patents are related to certain cannabinoid infused beverage compositions utilizing Lexaria's proprietary DehydraTECHTM process which continue to strengthen the Company's dominant intellectual property in the important cannabis beverage market. Newly granted patent numbers 10,103,225 and 10,084,044 provide protection for compositions as well as methods for making the compositions, each of which include the use of both non-psychoactive cannabinoids such as CBD and also psychoactive cannabinoids such as THC. Lexaria is currently pursuing accelerated examination for patent applications in Australia based on these newest US patents and hopes to receive two corresponding Australian patents granted by the end of 2018.

Emblem Corp. (OTCQX: EMMBF), through its wholly-owned subsidiary Emblem Cannabis Corporation, is a fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives in Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR). Emblem Corp. recently announced that its wholly-owned subsidiary, Emblem Cannabis Corporation, one of Canada's leading licensed producers of medical cannabis, has received approval to supply British Columbia and Saskatchewan with premium cannabis products under Emblem's adult-use brand, Symbl. "B.C. and Saskatchewan are important markets for Emblem's continued domestic growth plans and we look forward to working with each province as a trusted partner to supply consumers with high-quality cannabis products that will meet their needs now and into the future," said Nick Dean, Chief Executive Officer, Emblem Corp. "Emblem is focused on building a business for the long-term through product innovation, developing strong brands and enhanced distribution. With supply approvals in place across four key provinces - which also includes Ontario and Alberta - we continue to expand Emblem's footprint and open up additional markets for our brands and products."

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Article category: 
Regional Marijuana News: